{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Miramar",
      "state": "FL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91712",
      "recalling_firm": "AVEVA Drug Delivery Systems, Inc.",
      "address_1": "3250 Commerce Pkwy",
      "address_2": "N/A",
      "postal_code": "33025-3907",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0466-2023",
      "product_description": "Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC  60505-7079-05",
      "product_quantity": "5,208 cartons",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.",
      "recall_initiation_date": "20230215",
      "center_classification_date": "20230314",
      "termination_date": "20240430",
      "report_date": "20230322",
      "code_info": "Lot#: 51836 Exp: 07/2023"
    }
  ]
}